Ixekizumab | 2 Minute Medicine

#VisualAbstract: IL-17 inhibitors are associated with higher treatment persistence than TNF inhibitors in patients with psoriasis and psoriatic arthritis

byKathleen Lau

April 7, 2022

0

#VisualAbstract: Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X)

byConstance Wu

January 5, 2020

0

1. Ixekizumab, an IL-17 inhibitor, elicits disease response in patients with non-radiographic active axial spondyloarthritis who have failed treatment with ...

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X)

byDonna Leetand1 others

December 22, 2019

0

1. Ixekizumab, an IL-17 inhibitor, elicits disease response in patients with non-radiographic active axial spondyloarthritis who have failed treatment with ...

2 Minute Medicine Rewind December 9, 2019

byDonna Leetand2 others

December 19, 2019

0

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 1. Obeticholic ...